PACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook
PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings
Pacific Biosciences: Q2 Earnings Snapshot
MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) ("PacBio"), a leading developer of high-quality, highly accurate sequencing solutions, today...
MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026. Recent Business Highlights Total revenue of...
MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry...
Barchart Research What to Expect from PACB Earnings PACB Generated August 4, 2026 Current Price $1.4400 EPS Estimate $$-0.14 Consensus Rating Moderate Buy Average Move 10.34% Can PacBio Finally Show the...
PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect
3 Russell 2000 Stocks That Fall Short
1 Russell 2000 Stock on Our Watchlist and 2 That Underwhelm